Cargando…
New approaches for developing biomarkers of hormonal contraceptive use
To identify biomarkers of hormonal contraceptive (HC) use in urine and saliva, we conducted a pilot study with 30 women initiating levonorgestrel (LNG) containing combined oral contraceptives (COCs) or depot medroxyprogesterone acetate (DMPA) (15/group). Based on established COC pharmacokinetics, we...
Autores principales: | Sachdeva, Rakhee, Kumar, Narender, Brache, Vivian, Friedland, Barbara A., Plagianos, Marlena, Zhang, Shimin, Kizima, Larisa, Cochon, Leila, Tabar, Ana Sofía Tejada, Blanc, Ann, Merkatz, Ruth B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816169/ https://www.ncbi.nlm.nih.gov/pubmed/36604469 http://dx.doi.org/10.1038/s41598-022-24215-4 |
Ejemplares similares
-
Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials
por: Archer, David F, et al.
Publicado: (2019) -
OR33-5 Low Systemic Levels of Segesterone Acetate are Required to Inhibit Ovulation in Women
por: Archer, David, et al.
Publicado: (2019) -
A randomized crossover study to evaluate local tolerability following subcutaneous administration of a new depot medroxyprogesterone acetate contraceptive formulation()
por: Halpern, Vera, et al.
Publicado: (2023) -
Clinical trial to evaluate pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after subcutaneous administration of Depo-Provera
por: Halpern, Vera, et al.
Publicado: (2021) -
SAT-219 A Novel 1-Year Contraceptive Vaginal System Delivering Segesterone Acetate and Ethinyl Estradiol: Effects on Lipids and other Hepatic Proteins
por: Archer, David, et al.
Publicado: (2019)